| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entasis Therapeutics Holdings Inc. | VP, Principal Fin & Acct Off | Common Stock | 0 | $2.20 | 11 Jul 2022 | Direct | |
| Entasis Therapeutics Holdings Inc. | VP, Principal Fin & Acct Off | Stock Option (right to buy) | 0 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc. | 11 Jul 2022 | 2 | $0 | 4 | VP, Principal Fin & Acct Off | 11 Jul 2022, 16:11 |
| ETTX | Entasis Therapeutics Holdings Inc. | 24 Feb 2022 | 1 | $0 | 4 | VP, Principal Fin & Acct Off | 25 Feb 2022, 15:30 |
| ETTX | Entasis Therapeutics Holdings Inc. | 24 Feb 2022 | 0 | $0 | 3 | VP, Principal Fin & Acct Off | 25 Feb 2022, 15:30 |